Business Wire - Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR
Thursday, December 11th, 2008 Business Editors & Health/Medical Writers
BIOWIRE2K
SEATTLE & PHILADELPHIA–(BW HealthWire)–March 25, 2002
Corixa Corporation (Nasdaq:CRXA) and GlaxoSmithKline (NYSE:GSK), today announced that Corixa has notified th…
